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Bovine Albumin (BSA) and lysozyme have been 
chemically transfonned into macroinitiators for the synthesis 
of fluorescent bioconjugates by living radical polymerization. 
A new fluorescent monomer based on rhodamine B has been 
synthesized and incorporated into the polymer backbone of the 
bioconjugate by copolymerization. This provides a new 
strategy for the synthesis of fluorescent bioconjugates with 
improved traceability in biological environments, during 
biomedical assays. 
  
1
 Introduction 
Protein-polymer conjugates is an emerging research area, representing an 
established way to new and more efficient therapeutics for application in 
biotechnology and medicine. Bioconjugation often refers to the linking of a 
(macro)molecule to (poly)peptides/proteins in order to form new chemical 
entities which are able to retain the bioefficacy and features of the peptide whilst 
enjoying enhancements fyom the polymer. The most significant example is the 
covalent modification of proteins with poly( ethylene glycol) (PEG), pegylation 
(1,2,3,4). The resulting conjugates exhibited multiple benefits including 
improved biodistributions and pharmacokinetics, improved resistance to 
proteolysis, reduced immunogenicity/antigenicity, longer plasma half-life and 
improved solubility when compared to non-pegylated counterparts (5). The 
emergence of living radical polymerization (LRP) has provided an efficient tool 
to design the nature and characteristics of the polymer conjugated to the protein. 
Transition-metal-mediated living radical polymerization (also called atom 
transfer radical polymerization, A TRP) ( 6, 7), nitroxide-mediated polymerization 
(NMRP) (8) and reversible transfer as reversible addition fragmentation transfer 
(RAFT) (9) allow various tailor-made polymers featuring unique properties in 
terms of molecular weight, molar mass distribution and chi;tin-end functionality 
to be synthesized. This provides a powerful tool for protein/peptide biology. 
Protein and peptides currently constitute appr<?ximately I 0% of the market for 
molecular medicines (total > 400 bn USD) which is growing year on year. As 
such; technological developments can have a real and immediate impact in 
this area. 
We have recently reported studies involving the "grafting to" strategy for 
synthesizing bioconjugates by copper-mediated living radical polymerization, 
the conventional route for pegylation. a-Functional well-defined polymers were 
used as alternative pegylation agents and reacted with residual amines (lysine 
and N-terminal a-amino residues) and thiols (cysteine residues) present at the 
surface of proteins (10, 11, 12). In contrast, the "grafting from" synthetic route, 
which consists of transforming a protein into a macroinitiator for subsequent 
polymerization, has not been as widely investigated ( 13, l 4). 
In this present work, we present a strategy for synthesizing fluorescent 
bioconjugates by LRP starting from previously modified proteins as 
macroinitiators. Materials containing fluorescent tags are extremely useful due to 
their increased traceability in biological systems during biomedical assays as the 
location of the material can be observed and hence its effectiveness may be 
determined. In addition, they can be observed using fluorescence microscopy 
and especially laser scanning confocal microscopy. 
2
 Experimental Part 
Materials 
Albumin, from bovine serum (BSA, molecular weight -66 kDa, V fraction), 
lysozyme (molecular weight -14.3 kDa), poly(ethylene glycol) methyl ether 
methacrylate (PEGMA475, average Mn = 475 g.mor', Aldrich), 2-
(dimethylamino)ethyl methacrylate (DMAEMA, Aldrich, 99%) and 
methacryloyl chloride (Aldrich, 97%) were used as received without further 
purification. Copper(I) bromide was purified by stirring over glacial acetic acid 
and followed by rinsing with ethanol and diethyl ether. Anhydrous dimethyl 
sulfoxide (DMSO, Aldrich, 99%), triethylamine (TEA, Fischer, 99%, stored 
over potassium hydroxide pellets), dichloromethane (DCM, Fischer, >99%), 
acetonitrile (BDH, 99.9%, HPLC grade) and trifluoroacetic acid (TFA, Aldrich, 
99%) were used as received. N-(Ethyl)-2-pyridylmethanimine was prepared as 
described earlier (/5) and stored under dinitrogen atmosphere at 4 °C. Hostasol 
methacrylate fluorescent monomer, maleimide and N-succinimidyl 2-bromo-2-
methylpropionate initiators were prepared as described elsewhere (/ 6, 11, 12). 
Analytical techniques 
1H NMR and 13C NMR spectra were recorded on a Bruker DPX 400 
spectrometer using deuterated chloroform (CDC'3, Aldrich) as a solvent. 
Fluorescence spectroscopy was performed on a Perkin Elmer LS SOB 
spectrofluorometer with I cm quartz cuvette at 200 nm.min"1 scan speed, 2.5 nm 
excitation and emission slit widths, ambient temperature in phosphate buffer (I 0 
mM, pH= 7.1). U.V.-Visible spectroscopy analysis was performed on a Jasco 
V-550 spectrophotometer with I cm quartz cuvette, 0.5 nm data pitch, 200 
nm.min"1 scan speed, ambient temperature in phosphate buffer (JO mM, pH = 
7.1). Circular Dichroism (CD) analysis was performed on a Jasco J715 
spectropolarimeter with 0.1 cm quartz cuvette, 0.2 nm data pitch, 100 nm.min·1 
scan speed, 8 accumulations, ambient temperature in phosphate buffer (JO mM, 
pH= 7.1) for a concentration ofO.I mg.mL"1• Percentages of ex-helices and~­
sheets were determined by applying the protein CD structure-fitting program, 
CDSSTR ( 18). 
The RP-HPLC system was fitted with a Phenomenex column (Jupiter, C18, 
4.6 x 250 mm, S µm, 300 A) and a U.V. detector (Gilson, UV-VIS-155) at 280 
nm under a flow rate of 1 mL.min"1• The separation was performed under a 
gradient between mobile phase A (acetonitrile/water, 90/10, v/v and 0.05% 
TFA) and mobile phase B (100% acetonitrile, 0.04% TFA). The gradient 3
involved several linear steps: 0 min 90% A,.27 min 40% A, 35 min 40% A, 37 
min 90% A, and 45 min 90% A. SEC-FL-HPLC system was carried out on two 
BioSep-SEC-S3000 columns with fluorescence detection (Hitachi, L-7480) 
continuously measuring the relative intensity of the mobile phase. The system 
was eluted with 0.1 vol.% TFA in water and acetonitrile (69/31, v/v) at a flow 
rate of0.5 mL.min·1• 
SDS-PAGE was conducted using a stacking polyacrylamide gel of 5% 
cross-linking, a resolving polyacrylamide gel (8% cross-linking for BSA 
conjugates; 12% cross-linking for lysozyme conjugate) and a running buffer 
consisting of 25 mM of TRIS base, 250 mM of glycerol, O. l % of SDS at pH 8. 7, 
bromophenol blue with addition of DTT for reducing conditions (17). 
Synthesis of rhodamine B methacrylate monomer 
Both TEA (1.44 g, 14.3 mmol) and methacryloyl chloride (0.97 g, 10.7 
mmol) were sequentially added at 0 °C to a solution ofrhodamine B (19) 
(5.93 g, 9.80 mmol) in DCM (100 mL),. After 1 h, the temperature was raised to 
ambient temperature and the mixture stirred for a further 12 h. The volatiles 
were then removed under reduced pressure and the residue purified by a pre-
eluted flash chromatography (Si02) using metharioVtriethylamine (95/5), to give 
rhodamine B methacrylate monomer as purple glassy solid in 72% yield. 
1H NMR (400.03 MHz, CDCh, 298 K): 5 = 1.20 {t, J= 7.0Hz, 12H), 1.67-
1.76 (q, J = 6.8 Hz, 2H), l.78 (s, 3H), 2.24 (br s, 4H), 2.31 (t, J = 7.2 Hz, 2H), 
3.30 (br s, 4H), 3.50-3.55 (q, J = 7.3 Hz, 8H), 4.02 (t, J = 6.4 Hz, 2H), 5.38-
5.45 (m, IH), 5.91-5.96 (m, IH), 6.63-6.68 (d, J = 2.5 Hz, 2H), 6.80-6.91 (dd, 
J= 2.3, 9.5 Hz, 2H), 7.07-7.15 (d, J= 9.5 Hz, 2H), 7.19-7.25 (m, IH);7.41-
7.49 (m, IH), 7.51-7.61 (m, 2H). 13C NMR (100.59 MHz, CDCh, 298 K): 5 = 
12.50, 18.12, 25.51, 41.34, 46.01, 47.17, 52.19, 52.88, 54.48, 62.52, 96.11, 
113.52, 114.32, 125.40, 127.51, 129.77, 129.99, 130.06, 130.46, 131.91, 
135.17, 136.02, 155.44, 155.70, 157.54, 167.12, 167.22. IR (solid, ATR cell): v 
(cm"1) 3070 (=CH2), 1709 (C=O ester carbonyl), 1635 (C=O amide), 1582 (C=C 
aromatic), 1460 (C=C aromatic), 1250 (C-0 ester), 1169 (C-0 ester), 1070 (C-0 
ether). High resolution MS-ES calcd. for C39H49N40 4 (M+): 637.3754; found: 
637.3760. 
Preparation of protein-macroinitiators 
BSA-macroinitiator 
BSA (34 mg, 0.52 µmol) was dissolved in 4.6 mL of 100 mM phosphate 
buffer (pH= 7.0). A solution of 15 mg ofmaleimide initiator (51.7 µmol) in 0.2 
4
 mL of DMSO was slowly added. The mixture was gently stirred for 12 h at 
ambient temperature and the solid residue was removed by centrifugation. The 
supernatant was diluted with deionized water and dialyzed with a 12,000-14,000 
molecular weight cut-off (MWCO) membrane against deionized water for 
several days. The solution was then lyophilized to isolate the BSA-
macroinitiator. 
Lysozyme._macroinitiator 
N-Hydroxysuccinimide-2-bromo-2-methylpropionate (37 mg, 140 µmol) in 
400 µL of DMSO was added to lysozyme (100 mg, 7.0 µmol) dissolved in 20 
mL of phosphate buffer ( l 00 mM, pH = 7 .0). To this, 50 
50 µL of TEA in 0.16 mL of phosphate 
buffer (100 mM, pH= 7.0), was added. The mixture was incubated at ambient 
temperature during 48 h under gentle stirring. The suspension was diluted with 
water and the solid residue was removed by centrifugation. The supernatant was 
dialyzed using a 6,000-8,000 MWCO membrane against deionized water for 
several days. The solvent was removed by lyophilization to isolate the lysozyme-
macroinitiator. 
Preparation of fluorescent bioconjugates 
BSA-poly(PEGMA.m-co-rhodamine B methacrylate) 
BSA-macroinitiator (100 mg, 1.5 µmol), PEGMA475 (0.11 g, 0.38 mmol) 
and Cu(l)Br (32 mg, 0.23 mmol) were placed in a Schlenk tube and were 
dissolved in 23.8 mL of deionized water. 200 µL of a stock solution of 
rhodamine B monomer (3.8 µmol), previously prepared by dissolving 25 mg of 
the rhodamine B monomer in 2 mL of deionized water, was added. The solution 
was then deoxygenated by three freeze-pump-thaw cycles. Subsequently three 
vacuum-nitrogen cycles were applied and the Schlenk was placed in an oil bath 
at 25 °C. N-(Ethyl)-2-pyridylmethanimide (59 µL, 0.48 mmol) was added and 
the reaction mixture immediately turned dark brown/red. After 48 h under 
nitrogen atmosphere, the reaction medium was diluted with deionized water and 
bubbled with air overnight. The solid residue was removed by centrifugation and 
the supernatant was dialyzed using a 12,000-14,000 MWCO membrane against 
deionized water. The solution was lyophilized and the BSA-poly(PEGMA475-co-
rhodamine B methacrylate) conjugate was obtained as a purple solid. 
5
 BSA-poly(PEGMA475-co-hostasol methacrylate) 
BSA-macroinitiator (75 mg, 1.1 µmol), PEGMA475 (85 mg, 0.28 mmol) and 
Cu(I)Br (24 mg, 0.17 mmol) were placed in a Schlenk tube and dissolved in 
DMSO (17.8 mL). The hostasol monomer (l.3 mg, 2.8 µmol) was added and the 
mixture deoxygenated by three freeze-pump-thaw cycles. The Schlenk tube was 
placed in an oil bath at 25 °C and N-(ethyl)-2-pyridylmethanimide (44 µL, 0.36 
mmol) as a polymerization initiator (the reaction medium turned a dark 
brown/orange color). The mixture was stirred under inert atmosphere for 48 h 
prior to dilution with DMSO and bubbled with air overnight. The suspension 
was centrifuged and the supernatant was then diluted with deionized water. The 
solid residue was removed by centrifugation and the supernatant was dialyzed 
using a 12,000-14,000 MWCO membrane against deionized water. The solvent 
was removed by lyophilization in order to isolate a yellow solid. 
BSA-poly(DMAEMA-co-rhodamine B methacrylate) 
BSA macroinitiator (100 mg, 1.5 µmol) was dissolved in 23.6 mL of 
degassed water. A solution of DMAEMA (200 µL, 0.38 mmol) was added 
(prepared by dissolving 630 µL of DMAEMA in 2 mL of deionized water and 
adding some drops of HCI until pH 6.6). To this, 200 µL of a rhodamine B 
monomer solution (3.8 µmol), obtained by dissolving 25 mg of the fluorescent 
monomer in 2 mL of deionized water, was added. The mixture was 
deoxygenated with three freeze-pump-thaw cycles. Cu(l)Br (32 mg, 0.23 mmol) 
was subsequently added to the frozen mixture and three vacuum-nitrogen cycles 
were applied. Then, the Schlenk tube was placed in an oil bath at 25 °C under a 
nitrogen atmosphere. N-(Ethyl)-2-pyridylmethanimide (59 µL, 0.48 mmol), 
reaction mixture turned a dark brown/red color. After 17 hours, the 
polymerization medium was diluted with deionized water and bubbled with air 
overnight. The solid residue was removed by centrifugation and the supernatant 
dialyzed using a 12,000-14,000 MWCO membrane against deionized water for 
several days. The solution was lyophilized to give the conjugate as a purple 
solid. 
lysozyme-poly(PEGMAm-co-rhodamine B methacrylate) 
Lysozyme-macroinitiator (18 mg, l.l µmol), PEGMA475 (83 mg, 0.28 
mmol) and Cu(l)Br (24 mg, 0.17 mmol) were dissolved in 15 mL of deionized 
water. Rhodamine B monomer solution, 150 µL (2.8 µmol), 19 mg of the 
fluorescent monomer in 2 mL of deionized water, was added. The solution was 
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 subsequently deoxygenated by three freeze-pump-thaw cycles and placed in an 
oil bath at 25 °C. N-(Ethyl)-2-pyridylmethanimide (44 µL, 0.35 mmol) was 
added, the reaction mixture immediately turning dark brown/red. The mixture 
was stirred for 48 hours under nitrogen. The reaction medium was then diluted 
with deionized water and bubbled with air overnight. The mixture was 
centrifuged to remove the solid residue and the supernatant dialyzed using a 
12,000-14,000 MWCO membrane against deionized water. The solution was 
then lyophilized to isolate the desired conjugate as a purple solid. 
Results and Discussion 
Synthesis of the rhodamine B methacrylate monomer as a fluorescent probe 
Fluorescent bioconjugates were prepared by in situ incorporation of the 
fluorescent probe during the synthesis of the polymer by copolymerization of 
fluorescent monomers with poly(ethylene glycol) methyl ether methacrylate 
(PEGMA475) or with dimethyl aminoethyl methacrylate (DMAEMA). Both the 
hostasol methacrylate monomer (/ 6) and novel fluorescent methacrylate 
monomer derived from rhodamine B (Scheme l) were employed. 
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Scheme/. Synthesis of the rhodamine B methacrylate monomer. 
The method proposed by Francis et al. (19) allowed the preparation of a 
rhodamine B-based alcohol which was subsequently transformed into the 
corresponding methacrylate monomer by reaction with methacryloyl chloride. 
This synthetic route was chosen for three main beneficial reasons: (i) contrary to 
secondary amides of rhodamine, tertiary amides to not undergo intramolecular 
cyclization which results in a loss of fluorescence; (ii) this fluorescent compound 
is highly soluble in aqueous solutions and retains its fluorescence emission under 
a broad range of pH and (iii) it enlarges our range of fluorescent probes. 
The resulting rhodamine B methacrylate monomer was obtained with high 
purity and gave a Aex. = 566 nm with Aem. = 587 nm in I 0 mM PBS buffer (pH 
7
 7. l) (Figure 1 ), leading to a Stokes shift of 21 run in agreement with rhodamine 
B-tertiary amide spectral properties (19). 
BSA fluorescent bioconjugates 
Synthesis and characterization of the BSA-macroinitiator 
Bovine Serum Albumin (BSA) is a 66 k.Da commercially available protein 
which was been selected as a model protein. The synthetic route for the synthesis 
of fluorescent bioconjugates based on BSA is represented in Scheme 2. The 
synthesis of the BSA-macroinitiator utilized the free cysteine residue (Cys-34) as 
a reactive functional group towards the maleimide initiator. It is known that only 
approximately 40-60% of free cysteine residues are available for protein 
modification in native BSA (20) and the number of thiols at the protein surface 
can be increased by appropriate reduction of disulfide bridges, although the 
latter approach mainly led to statistical multisite conjugation (13). In the present 
work we chose to prepare a BSA-monoinitiator using native BSA as the starting 
material, with unreacted non-thiol-containing BSA being the only observed 
byproduct. 
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Figure 1. Absorption (dashed line) and emission(solid line) spectra of the 
rhodamine B methacrylate monomer in JO mM PBS buffer (pH 7.1). 
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Scheme 2. Synthesis of the BSA fluorescent bioconjugates. 
Each step of the synthesis of the bioconjugate was monitored by Sodium 
Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SOS-PAGE). Compared to 
the native BSA (band at 66 kDa), the BSA-macroinitiator exhibited two visible 
bands: The most significant band was slightly higher than 66 kDa and the second 
was spread out from 200 kDa to higher molecular weight (Figure 2). The 
presence of the second band can be ascribed to the aggregation phenomenon in 
which BSA oligomerizes via intermolecular thiol-disulfide interchange reaction 
(21). However, the relative intensities of the two bands indicate that only a minor 
fraction of BSA starting material undergoes oligomerization. SOS-PAGE 
analysis also revealed that traces of high molecular weight oligomers were 
already present in the commercially available native BSA. 
BSA oligomerization has been reported to induce some protein 
conformational changes, especially a decrease of the a-helix accompanied by an 
increase of f3-sheet substructures (21). Circular dichroism (CD) analysis of 
native BSA 
f3-sheet content increased from l to 8% by passing 
from the former to the latter. This may be ascribed to the presence of oligomeric 
impurities in the BSA-macroinitiator, although a conformational change due to 
the attachment of the initiator moiety to the BSA cannot be ruled out. 
9
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Figure 2. SDS-PAGE of (a) native BSA, (b) BSA-macroinitiator, (c) BSA-
poly(DMAEMA-co-rhodamine B methacrylate), (d) BSA-poly(PEGMA475-co-
rhodamine B methacrylate) and (e) BSA-poly(PEGMA 475-co-rhodamine B 
methacry/ate) under U. V. light at A. = 302 nm. 
RP-HPLC using a C 18 column (Figure 3) showed separation between native 
BSA (retention time= 17.0 min) and BSA-macroinitiator (retention time= 19.5 
min), The BSA-macroinitiator also presented small peak observed at 14.6 min, 
ascribed to the presence of BSA oligomers. 
Synthesis and spectral properties of the BSA fluorescent bioconjugates 
The isolated BSA-macroinitiator was used to initiate the polymerization of 
PEGMA475 and DMAEMA using both hostasol and rhodamine B methacrylate 
fluorescent comonomers. After 48 h of polymerization at ambient temperature, 
the bioconjugates were purified and isolated by dialysis and lyciphilization in 
order to remove unreacted monomers, especially remaining fluorescent 
monomers. The bioconjugation reaction was assessed by SDS-PAGE (Figure 2) 
where a shift from the BSA-macroinitiator to higher molecular weight was 
observed for both PEGMA475 and DMAEMA polymerizations. Due to the 
incorporated rhodamine B fluorescent probe, the bioconjugate can also be 
detected by U.V. excitation (A.= 302 nm). 
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Figure 3. RP-HPLC of native (a) BSA, (b) control experiment and (c) BSA-
macroinitiator. Control experiment: BSA in PBS (JOO mM, pH= 7.0) with 
DMSO. stirred overnight at ambient temperature. 
As expected, solutions of the bioconjugates in phosphate buffer (10 mM, pH 
7. I) exhibited a strong fluorescence in agreement with the respective 
excitation/emission spectra of the rhodamine B and hostasol methacrylate 
fluorescent monomers (Figure 4). 
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 With both copolymerized fluorescent monomers the obtained fluorescent 
bioconjugates could be detected by SEC~HPLC with fluorescence detection (at 
appropriate Aex. and Aem. for each fluorescent monomer) (Figure 5). This 
confirmed that the fluorescent probes had been incorporated in situ into the 
synthetic polymer-protein conjugate during the polymerization. In addition, 
SEC-FL-HPLC analysis revealed the absence of unreacted fluorescent 
monomers in the bioconjugate samples. 
Lysozyme fluorescent bioconjugate 
Synthesis of the lysozyme-macroinitiator 
In order to demonstrate the flexibility of this approach, a similar synthetic 
route was investigated with lysozyme. The strategy for conducting 
bioconjugation was to target the free amine groups for multi-site attachment with 
the N-succinimidyl 2-bromo-2-methylpropionate (Scheme 3). 
RP-HPLC analysis showed an almost complete disappearance of the native 
lysozyme peak along with the appearance of the lysozyme-macroinitiator peak. 
The re.lative broadness of the latter may indicate the presence of a statistical 
macroinitiators mixture in which different number of bromoisobutyrate initiator 
moieties are bound to the lysozyme core. The SOS-PAGE did not show any 
noticeable difference between the native lysozyme and the lysozyme-
macroinitiator (Figure 6); in particular no formation of side products at higher 
molecular weight was observed. 
Synthesis and characterization of the lysozymefluor(!scent bioconjugate 
The lysozyme-macroinitiator was used for the polymerization of PEGMAm 
in aqueous solution under living radical polymerization conditions with the 
rhodamine B monomer as a fluorescent probe. After polymerization, the 
lysozyme-poly(PEGMA475-co-rhodamine B methacrylate) conjugate was 
purified and isolated by dialysis and lyophilization in order to remove unreacted 
monomers. The spectral properties of the fluorescent lysozyme bioconjugate 
were determined and, as expected, absorption and emission spectra of the 
bioconjugate are in very good agreement with those of pure rhodamine B 
monomer (Figure 7). 
The lysozyme-poly(PEGMA475-co-rhodamine B methacrylate) conjugate 
was observed by SEC-HPLC equipped with fluorescence detection (A.ex. = 566 
run and "-em. = 596 run), which confirmed the incorporation of the fluorescent 
probe in situ during the polymerization reaction of PEGMA475 initiated by the 12
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Figure 5. Top: SEC-FL-HPLC ofBSA-poly(PEGMAm-co-rhodamine B 
methacrylate) bioconjugate and of the rhodamine B methacry/ate monomer. 
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methacrylate) bioconjugate and of the rhodamine B monomer, II.ex. = 566 nm 
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Scheme 3. Synthesis of the lysozyme fluorescent bioconjugate by living 
radical polymerization. 
 
lysozyrne-macroinitiator (Figure 8). A broad peak for the lysozyme bioconjugate 
was observed, probably due to the use of lysozyme-macroinitiators featuring a 
different number of initiating centers, which induced a broader molar mass 
distribution in the resulting biohybrid material, a behaviour that is commonly 
observed in living radical polymerization using multifunctional initiators. 
Conclusions 
Bovine serum albumin and lysozyme have been transformed into 
macroinitiators for the synthesis of fluorescent bioconjugates exploiting living 
radical polymerization. For this purpose, we have designed and synthesized a 
new fluorescent methacrylate monomer derived from rhodamine B. The 
bioconjugation reactions were assessed and these bioconjugates were detected 
by HPLC with fluorescent detection, giving rise to a new strategy for in situ 
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Figure 6. SDS-PAGE of (a) native lysozyme, (b) lysozyme-macroinitiator, (c) 
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Figure 7. Absorption (dashed line) and emission (solid line) spectra of the 
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bioconjugate. 15
:i 
Iii 
10 
Lysozyme-poly(PEGMA-cCMhodamine) 
20 30 40 
Time/ min 
 
Rhodamine monomer 
50 60 
Figure 8. SEC-FL-HPLC of/ysozyme-poly(PEGMA475-co-rhodamine B 
methacrylate) bioconjugate and of the rhodamine B methacrylate monomer (A.ex. 
= 566 nm and A.em.= 596 nm). 
observation of delivered compounds.22 This strategy is quite generic and 
applicable to a wide range of proteins and peptides. 
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